Dedicated to Research Since 1993
  •  

    info@genesismarketinsights.com

Stem Cell Market By Type (Allogeneic Stem Cell Therapy , Autologous Stem Cell Therapy ), By Cell Source (Adipose Tissue-Derived Mesenchymal Stem Cells , Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells ) By Application (Musculoskeletal Disorders, Wounds and Injuries, Cardiovascular Diseases ) - Global Opportunity Analysis and Industry Forecast, 2018-2023

 Healthcare and Pharmaceuticals

Report Overview

GLOBAL STEM CELL THERAPY MARKET was valued at USD 105.24 Million in the year 2017. Global Stem Cell Therapy market is further estimated to grow at a CAGR of 12.33% from 2018 to reach USD 211.39 Million by the year 2023. North America region holds the highest market share in 2017 and the market is also considered as the fastest growing market in the forecasted period. At a country level, the U.S. is projected to grow strongly in the coming years. The growth is attributed to the presence of key market players, growing awareness of the stem cell usage in the various application in disorders such as central nervous system disorders, cardiovascular diseases, neurodegenerative diseases, metabolic, eye, and immune system.

Osiris Therapeutics, Inc. (U.S.), Holostem Terapie Avanzate S.r.l. (Italy), JCR Pharmaceuticals Co., Ltd. (Japan), NuVasive, Inc. (U.S.), Anterogen Co., Ltd. (South Korea), Pharmicell Co., Ltd. (South Korea), MEDIPOST Co., Ltd. (South Korea), RTI Surgical, Inc. (U.S.), and AlloSource (U.S.) are some of the key players in the Global Stem Cell Therapy market. Organic growth techniques such as expanding global presence along with increasing research and development activities to address the changing demand of the healthcare industry were few techniques adopted by most of Tier 1 and Tier 2 manufacturers in recent years.

Drivers:

             Growing Awareness Related to the Therapeutic Potency and effectiveness for Infection Management

             Growing Public-Private Investment models for the Expansion of the Stem Cell Therapies in the developed regions

Restraints:

             Varied Regulatory Guidelines across regions pertaining to for new Product Development.

Opportunities:

             Government supportive regulations across regions for the use of stem cell in improving the disease management.

Challenges:

             Low Awareness in emerging market due to the Technical Limitations

Stem Cell Therapy market on the basis of various application, the autologous stem cell therapy is further subcategorized into cardiovascular diseases, wounds, and injuries, gastrointestinal diseases. The allogeneic stem cell therapy segment is estimated to grow at the highest CAGR till 2023. This growth is attributed to the growing usage of the allogeneic stem cell therapy products along with its broad therapeutic uses.

Further, Stem Cell Therapy market when segmented on the basis of source type Bone Marrow and Adipose Tissue both hold substantial market share in 2017. The reason being a development of greater genome-based cell investigation methods.

Key Benefits for Stakeholders

Stem Cell Therapeutic Product Manufacturers, Distributors and Retailers

Research and Development companies

Healthcare service providers like hospitals, laboratories, diagnostic centers

Pharmaceutical companies

Technology Standards Organizations, Forums, Alliances and Associations

Regulatory bodies, Stem Cell Associations and Organizations

By Type

Allogeneic Stem Cell Therapy Market, By Application

           Musculoskeletal Disorders

           Wounds and Injuries

           Surgeries

           Acute Graft-Versus-Host Disease (AGVHD)

Autologous Stem Cell Therapy Market, By Application

           Wounds and Injuries

           Cardiovascular Diseases

           Gastrointestinal Diseases

By Cell Source

Adipose Tissue-Derived Mesenchymal Stem Cells

Bone Marrow-Derived Mesenchymal Stem Cells

Cord Blood/Embryonic Stem Cells

By Application

Musculoskeletal Disorders

Wounds and Injuries

Cardiovascular Diseases

Surgeries

Gastrointestinal Diseases

By Region

North America

Europe

Asia-Pacific

RoW

Key Market Players

Medipost Co., Ltd.

Anterogen Co., Ltd.

Pharmicell Co., Ltd.

Holostem Terapie Avanzate Srl

JCR Pharmaceuticals Co., Ltd.

Osiris Therapeutics, Inc.

Nuvasive, Inc.

RTI Surgical, Inc.

(A brief overview of another 13 companies is also provided)

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1. Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2. Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3. To avoid bias, we filter the collected data collected from authenticated sources.
  4. GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5. Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.
  6. Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

             2.1.1.1. Key Data from Secondary Research

       2.1.2. Primary Research

             2.1.2.1. Key Data from Primary Research

             2.1.2.2. Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottoms-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. Stem Cell Therapy Market, By Type

6.1 Allogeneic Stem Cell Therapy Market, By Application

      6.1.1 Musculoskeletal Disorders

      6.1.2 Wounds and Injuries

      6.1.3 Surgeries

      6.1.4 Acute Graft-Versus-Host Disease (AGVHD)

6.2 Autologous Stem Cell Therapy Market, By Application

      6.2.1 Wounds and Injuries

      6.2.2 Cardiovascular Diseases

      6.2.3 Gastrointestinal Diseases

7. Stem Cell Therapy Market, By Cell Source

7.1 Adipose Tissue-Derived Mesenchymal Stem Cells

7.2 Bone Marrow-Derived Mesenchymal Stem Cells

7.3 Cord Blood/Embryonic Stem Cells

8. Stem Cell Therapy Market, By Component

8.1 Musculoskeletal Disorders

8.2 Wounds and Injuries

8.3 Cardiovascular Diseases

8.4 Surgeries

8.5 Gastrointestinal Diseases

9. Geographical Analysis

9.1. Introduction

9.2. North America

       9.2.1. U.S.

       9.2.2. Canada

       9.2.3. Mexico

9.3. Europe

       9.3.1. U.K.

       9.3.2. Germany

       9.3.3. France

       9.3.4. RoE

9.4. Asia Pacific

       9.4.1. South Korea

       9.4.2. China

       9.4.3. Japan

       9.4.4. RoAPAC

9.5. RoW

       9.5.1. Latin America

       9.5.2. Middle East and Africa

10. Company Profiles

(Business Overview, Financial Overview, Product write Up, Recent Developments)

10.1 Medipost Co., Ltd.

10.2 Anterogen Co., Ltd.

10.3 Pharmicell Co., Ltd.

10.4 Holostem Terapie Avanzate Srl

10.5 JCR Pharmaceuticals Co., Ltd.

10.6 Osiris Therapeutics, Inc.

10.7 Nuvasive, Inc.

10.8 RTI Surgical, Inc.

10.9 Allosource.

(A brief overview of 13 companies is also provided)

11. Competitive Analysis

11.1. Introduction

11.2. Market Positioning of Key Players

11.3 Competitive Strategies Adopted by Leading Players

        11.3.1. Investments & Expansions

        11.3.2. New Product Launches

        11.3.3. Mergers & Acquisitions

        11.3.4. Agreements, Joint Ventures, and Partnerships

12. Appendix

12.1. Questionnaire

12.2. Available Customizations 

12.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)

Summary

No Content Available.